title: Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking.
abstract: There is growing preclinical evidence for the involvement of glutamate in the behavioral actions of nicotine. The aim of this study, was to investigate the role of N-methyl-D-aspartate (NMDA) receptors in the cognitive and subjective effects of smoking in humans. Sixty regular smokers took part in this double-blind placebo controlled study, that investigated the effect of the NMDA-antagonist memantine (40 mg) and the nicotinic-receptor antagonist mecamylamine (10 mg) on smoking-induced improvement in performance of a task of sustained attention and on smoking-induced changes in subjective effects and craving. Increases in subjective ratings of 'buzzed' following smoking were reversed by memantine, but not by mecamylamine. In contrast, improvement on a Rapid Visual Information Processing task by smoking was opposed by mecamylamine, but not by memantine. Smoking reduced craving for cigarettes, but neither drug altered this effect. Our results suggest that glutamatergic mechanisms may have differential involvement in the subjective and cognitive actions of smoking. Further investigations using different ligands are warranted to fully characterize the role of glutamate underlying the consequences of smoking behavior.
authors.affiliation: School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton, UK. aj4@bton.ac.uk
authors.forename: A
authors.initials: A
authors.lastname: Jackson
authors.forename: J
authors.initials: J
authors.lastname: Nesic
authors.forename: C
authors.initials: C
authors.lastname: Groombridge
authors.forename: O
authors.initials: O
authors.lastname: Clowry
authors.forename: J
authors.initials: J
authors.lastname: Rusted
authors.forename: T
authors.initials: T
authors.lastname: Duka
mesh_terms: D000293:Adolescent; D000328:Adult; D001288:Attention / Q000187:drug effects; D016739:Behavior, Addictive / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D003071:Cognition / Q000187:drug effects*; D004311:Double-Blind Method; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology*; D008559:Memantine / Q000494:pharmacology*; D008570:Memory, Short-Term / Q000187:drug effects; D018733:Nicotinic Antagonists / Q000494:pharmacology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology*; D012907:Smoking / Q000503:physiopathology* / Q000523:psychology*; D055815:Young Adult
chemical_list: D018733:Nicotinic Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D008464:Mecamylamine; D008559:Memantine